Researchers reported advances in immune-cell engineering that aim to improve the performance of prime editors. In separate work, structure-informed AI and directed evolution were used to redesign reverse transcriptase domains within prime-editing constructs, with redesigned agents showing improved folding, soluble expression, and editing efficiency in ex vivo contexts and mouse models.